Crossmark

Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy

Published Online: 2015-03-27

Authors

Snyder, Kimberly A

Hughes, Michael R

Hedberg, Bradley

Brandon, Jill

Hernaez, Diana Canals

Bergqvist, Peter

Cruz, Frederic

Po, Kelvin

Graves, Marcia L

Turvey, Michelle E

Nielsen, Julie S

Wilkins, John A

McColl, Shaun R

Babcook, John S

Roskelley, Calvin D

McNagny, Kelly M
License Information

Text and Data Mining valid from 2015-03-27

Version of Record valid from 2015-03-27
More Information

Article History

Received: 22 June 2014

Accepted: 17 March 2015

First Online: 27 March 2015

Document is current